This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: sudden death

August 2017 Br J Cardiol 2017;24:117 doi:10.5837/bjc.2017.023

Brugada syndrome in the context of a fever: a case study and review of current knowledge

Saad Ahmad, Irfan Ahmed

Abstract

Case A 45-year-old woman with no significant past medical history presented to our hospital in October 2015 with coryzal symptoms. She complained of a sore throat, malaise and described a brief loss of consciousness. She was assessed and found to be febrile with a temperature of 38.3 degrees Celsius. Physical examination and work-up with blood tests and chest X-ray (CXR) were unremarkable. The working diagnosis was that of a flu-like illness. The patient was given reassurances and advised bed rest, fluids and paracetamol. She was discharged from hospital and it was not until her notes were reviewed by a consultant physician that a suspicion o

| Full text
Anomalous coronary artery origin: all three arising from right coronary cusp from separate ostia

February 2015 Br J Cardiol 2015;22:39 doi:10.5837/bjc.2015.005 Online First

Anomalous coronary artery origin: all three arising from right coronary cusp from separate ostia

Vickram Singh, Jeffrey Khoo

Abstract

Figure 1. Anteroposterior (AP) view, showing the hypoplastic left anterior descending (LAD) arising from right coronary cusp Introduction Coronary anomalies are congenital abnormalities in the coronary anatomy of the heart. They are found in approximately 1% of the population undergoing coronary angiography,1 and are often associated with other structural heart disease. Coronary artery anomalies are a cause of sudden death in the young athlete in the absence of additional heart abnormalities. The aim of this report is to revise this important but often neglected topic, its clinical implications, and to discuss a rare case that was recently en

| Full text
News from the American Heart Association Scientific Sessions 2009

February 2010 Br J Cardiol 2010;17:13-18

News from the American Heart Association Scientific Sessions 2009

BJCardio editorial staff

Abstract

ARBITER 6: niacin superior to ezetimibe for slowing atherosclerosis Use of extended-release niacin resulted in a significant benefit on atherosclerosis compared with ezetimibe in patients already taking statins in the ARBITER 6-HALTS trial. The trial, presented at the meeting by Dr Allen Taylor (Medstar Research Institute, Washington DC, US), compared two distinct lipid-modifying strategies in patients with known vascular disease already on statins who had LDL-cholesterol levels <100 mg/dL (2.56 mmol/L) and moderately low HDL-cholesterol levels (<50 mg/dL [1.28 mmol/L]). Among the 363 patients enrolled in the study, half were randomised

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now